Clinical trial
Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)
NCT00095043 · H. Lundbeck A/S, Industry · Completed
Key facts
| NCT number | NCT00095043 |
|---|---|
| Title | Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED) |
| Official title | A 12-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel Groups, Multicenter Long-Term Safety Study of MK0928 in the Treatment of Elderly Outpatients With Primary Insomnia |
| Lead sponsor | H. Lundbeck A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | MK0928, gaboxadol, Comparator: placebo |
| Enrollment | 320 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2006 |
| First posted | Nov 1, 2004 |
| Last update posted | Nov 17, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: